drugset / Trial / NCT01520285
Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will be compare Felodipine sustained-release tablets, to Lercanidipine hydrochloride tablets (Zanidip®) for the treatment of patients with mild-to-moderate primary hypertension and to investigate the influence on patients' heart rate and blood pressure variability.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-03
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Felodipine | Small molecule | 5 mg | Oral |
| Comparator | Lercanidipine | Small molecule | 10 mg | Oral |